An aspirin-free strategy and optical coherence tomography observations after percutaneous coronary intervention: Insights from the STOPDAPT-3 trial
J Cardiol
.
2024 May 10:S0914-5087(24)00083-2.
doi: 10.1016/j.jjcc.2024.05.002.
Online ahead of print.
Authors
Yuki Obayashi
1
,
Masahiro Natsuaki
2
,
Hirotoshi Watanabe
3
,
Takeshi Morimoto
4
,
Ko Yamamoto
5
,
Ryusuke Nishikawa
1
,
Akiyoshi Miyazawa
6
,
Nobuaki Suzuki
6
,
Satoru Suwa
7
,
Hidekuni Kirigaya
8
,
Kohei Wakabayashi
9
,
Kazuya Kawai
10
,
Yuko Onishi
11
,
Itsuro Morishima
12
,
Hideki Okayama
13
,
Hiroki Uehara
14
,
Kiyoshi Hibi
8
,
Koh Ono
1
,
Takeshi Kimura
15
;
STOPDAPT-3 Investigators
Affiliations
1
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
2
Department of Cardiovascular Medicine, Saga University, Saga, Japan.
3
Division of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.
4
Department of Clinical Epidemiology, Hyogo Medical University, Nishinomiya, Japan.
5
Department of Cardiology, Kokura Memorial Hospital, Kitakyusyu, Japan.
6
Cardiocore Japan, Tokyo, Japan.
7
Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
8
Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
9
Division of Cardiology, Showa University Koto Toyosu Hospital, Tokyo, Japan.
10
Department of Medicine and Cardiology, Chikamori Hospital, Kochi, Japan.
11
Department of Cardiology, Hiratsuka Kyosai Hospital, Hiratsuka, Japan.
12
Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
13
Department of Cardiology, Ehime Prefectural Central Hospital, Matsuyama, Japan.
14
Department of Cardiology, Urasoe General Hospital, Urasoe, Japan.
15
Division of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan. Electronic address: taketaka@kuhp.kyoto-u.ac.jp.
PMID:
38735384
DOI:
10.1016/j.jjcc.2024.05.002
No abstract available
Publication types
Letter